Sign In
St. John Health System
Lab Catalog


Index:

CA 15-3 Assay

Order Name CA15-3
Test Number: 2024000
Revision Date 04/17/2019
Test Name Methodology LOINC Code
CA 15-3 Assay
Chemiluminescence Assay 6875-9 
SPECIMEN REQUIREMENTS
Specimen Specimen Volume (min) Specimen Type Specimen Container Transport Environment
Preferred 2mL (1mL) Serum Clot Activator SST Refrigerated
Alternate 1 2mL (1mL) Plasma Lithium Heparin PST (Light Green Top) Refrigerated
Instructions Separate from cells within 2 hours after collection.
Stability: Ambient 1 day. Refrigerated 7 days. Frozen > 7 days.
GENERAL INFORMATION
Testing Schedule Mon - Fri 
Expected TAT 1-3 days 
Clinical Use Measurements of CA 15-3 in women with treated carcinoma of the breast may be useful for predicting early recurrence. The FDA has approved CA 15-3 for serial testing in women with prior stage II or III breast cancer who are clinically free of disease. 
CPT Code(s) 86300
Internal Comments 3/7/17 - Updated transport temp and stability info to: Specimen Stability: Room temperature: 8 hours, Refrigerated: 24 hours, Frozen: 30 days- JLS
7/14/ - Ryan update stability to: Stability: Room temperature: 8 hours, Refrigerated: 24 hours, Freeze if testing cannot be started within 24 hours - JK
5/22/18 removed Re-baseline Order Code ( 2024001 ) Re-Baseline: CA 15-3   /   Result Code ( 2024001 ) RB CA 15-3
6/4/18 updated stability to Stability: Ambient 1 day. Refrigerated 7 days. Frozen > 7 days.  Transport Refrig or Frozen - JK
6/14/18 Stability: Room temperature:  1 day. Refrigerated 7 days. Frozen > 7 days. -
Stability: Ambient 1 day. Refrigerated 7 days. Frozen > 7 days.
4/17/19 changed trans temp from ref/froz to just ref - JK
Service Provided By Labcorp Oklahoma, Inc.
Lab Section Chemistry